Karyopharm Therapeutics Inc.: in insolvency, 3 Nov 2026
pharmaceutical and biotechnology research
Handling Karyopharm Therapeutics Inc.'s insolvency, or own its records? Its records can still be sold, once, to several buyers at the same time, with the personal data removed first.
- No data upload
- About two minutes
- No email needed
- 8-K item 1.03: bankruptcy or receivership SEC filings (8-K), 3 Nov 2026
Public prices for a whole company's records run $135K to $492K per company in the middle of the market, and the highest public offer for one company's archive is $12.5M. What a closed company's records fetch depends on how many people wrote them, over how many years, and whether its accounts are still open: buyers pay for linked histories (code with its tickets, decisions with their discussion), and the deletion clock runs from the day the subscriptions stop. Which of its records the law still requires to be kept, for how long and by whom: How Long to Keep Business Records After Closing (US, UK, Canada).
Value the records of Karyopharm Therapeutics Inc. in a few minutes (free; for whoever owns them now)
- Listed
- Yes
- Country
- US
- MYDEX DATA SERVICES COMMUNITY INTEREST COMPANY, 2 Nov 2026
- REFORM CLOTHING LTD, 30 Oct 2026
- Kreatur Limited (Logically), 29 Oct 2026
- SALTOURS INTERNATIONAL LIMITED, 29 Oct 2026
- SCHAPPIT LTD, 27 Oct 2026
- SMARTFRAME TECHNOLOGIES LIMITED, 26 Oct 2026
About this page
Built each morning from public records only: no person is named and nothing private is used. Each signal links to its own record and to where it was read. If you represent Karyopharm Therapeutics Inc. and something here is wrong, tell us and it is corrected the same day.